Given the role of GM-CSF in myelopoesis and enhancement of neutrophil survival, alongside the neutrophil activation and dysfunctional myeloid cell populations observed in severe COVID-19 (59, 60), these trials may inform our understanding of the importance of this pathway in COVID-19 immunopathogenesis (56). The gene discussed is CSF2; the disease is COVID-19.